PFE
Price:
$26.705
Market Cap:
$151.34B
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disea...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
PFE
According to Pfizer Inc.’s latest financial reports and current stock price. The company's current ROE is 4.72%. This represents a change of 320.71% compared to the average of 1.12% of the last 4 quarters.
The mean historical ROE of Pfizer Inc. over the last ten years is 18.37%. The current 4.72% ROE has changed -74.32% with respect to the historical average. Over the past ten years (40 quarters), PFE's ROE was at its highest in in the December 2017 quarter at 17.21%. The ROE was at its lowest in in the December 2023 quarter at -3.76%.
Average
18.37%
Median
15.20%
Minimum
2.38%
Maximum
32.79%
Discovering the peaks and valleys of Pfizer Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.46%
Maximum Annual ROE = 32.79%
Minimum Annual Increase = -92.74%
Minimum Annual ROE = 2.38%
Year | ROE | Change |
---|---|---|
2023 | 2.38% | -92.74% |
2022 | 32.79% | 15.19% |
2021 | 28.47% | 156.46% |
2020 | 11.10% | -56.93% |
2019 | 25.77% | 46.52% |
2018 | 17.59% | -41.14% |
2017 | 29.88% | 146.61% |
2016 | 12.12% | 12.68% |
2015 | 10.75% | -16.06% |
2014 | 12.81% | -55.57% |
The current ROE of Pfizer Inc. (PFE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
21.22%
5-year avg
20.10%
10-year avg
18.37%
Pfizer Inc.’s ROE is less than AbbVie Inc. (65.72%), less than Merck & Co., Inc. (29.27%), less than Eli Lilly and Company (65.15%), greater than Bristol-Myers Squibb Company (-36.26%), less than Johnson & Johnson (20.94%), less than Amgen Inc. (68.49%), less than Gilead Sciences, Inc. (0.65%),
Company | ROE | Market cap |
---|---|---|
65.72% | $317.73B | |
29.27% | $251.57B | |
65.15% | $755.34B | |
-36.26% | $117.15B | |
20.94% | $351.15B | |
68.49% | $142.17B | |
0.65% | $117.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pfizer Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pfizer Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pfizer Inc.'s ROE?
How is the ROE calculated for Pfizer Inc. (PFE)?
What is the highest ROE for Pfizer Inc. (PFE)?
What is the 3-year average ROE for Pfizer Inc. (PFE)?
What is the 5-year average ROE for Pfizer Inc. (PFE)?
How does the current ROE for Pfizer Inc. (PFE) compare to its historical average?